Cargando…

SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5

Serine Incorporator 5 (SERINC5), a cellular multipass transmembrane protein that is involved in sphingolipid and phosphatydilserine biogenesis, potently restricts a number of retroviruses, including Human Immunodeficiency Virus (HIV). SERINC5 is incorporated in the budding virions leading to the inh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Timilsina, Uddhav, Umthong, Supawadee, Ivey, Emily B., Waxman, Brandon, Stavrou, Spyridon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135752/ https://www.ncbi.nlm.nih.gov/pubmed/35618710 http://dx.doi.org/10.1038/s41467-022-30609-9

Ejemplares similares

SERINC5 Potently Restricts Retrovirus Infection In Vivo
por: Timilsina, Uddhav, et al.
Publicado: (2020)

Elucidating the Antiviral Mechanism of Different MARCH Factors
por: Umthong, Supawadee, et al.
Publicado: (2021)

SERINC5: One antiviral factor to bind them all
por: Timilsina, Uddhav, et al.
Publicado: (2023)

Determining the antiviral mechanism of MARCH2
por: Umthong, Supawadee, et al.
Publicado: (2023)

Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5
por: Wu, Yuanfei, et al.
Publicado: (2019)

A fluorescence-based, gain-of-signal, live cell system to evaluate SARS-CoV-2 main protease inhibition
por: Dey-Rao, Rama, et al.
Publicado: (2021)

Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity
por: Diehl, William E., et al.
Publicado: (2021)

The Antiviral Factor SERINC5 Impairs the Expression of Non-Self-DNA
por: Shi, Yuhang, et al.
Publicado: (2023)

Proteasomal degradation of human SERINC4: A potent host anti-HIV-1 factor that is antagonized by nef
por: Qiu, Xusheng, et al.
Publicado: (2020)

SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef
por: Usami, Yoshiko, et al.
Publicado: (2015)

Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry
por: Leonhardt, Susan A., et al.
Publicado: (2023)

Impairment of antiviral immune response and disruption of cellular functions by SARS-CoV-2 ORF7a and ORF7b
por: García-García, Tránsito, et al.
Publicado: (2022)

SARS-CoV-2-encoded small RNAs are able to repress the host expression of SERINC5 to facilitate viral replication
por: Meseguer, Salvador, et al.
Publicado: (2023)

HIV-1 restriction by SERINC5
por: Cano-Ortiz, Lucía, et al.
Publicado: (2022)

Spotlight on HIV-1 Nef: SERINC3 and SERINC5 Identified as Restriction Factors Antagonized by the Pathogenesis Factor
por: Fackler, Oliver T.
Publicado: (2015)

Novel monoclonal antibodies to the SERINC5 HIV-1 restriction factor detect endogenous and virion-associated SERINC5
por: Molnar, Sebastian, et al.
Publicado: (2020)

Antiviral Role of Serine Incorporator 5 (SERINC5) Proteins in Classical Swine Fever Virus Infection
por: Li, Wenhui, et al.
Publicado: (2020)

Clinical characteristics and host immunity responses of SARS-CoV-2 Omicron variant BA.2 with deletion of ORF7a, ORF7b and ORF8
por: Tang, Zhizhong, et al.
Publicado: (2023)

SERINC5 restricts influenza virus infectivity
por: Zhao, Fei, et al.
Publicado: (2022)

Restriction of Influenza A Virus by SERINC5
por: Lai, Kin Kui, et al.
Publicado: (2022)

Identification of potent maturation inhibitors against HIV-1 clade C
por: Timilsina, Uddhav, et al.
Publicado: (2016)

Variation in HIV-1 Nef function within and among viral subtypes reveals genetically separable antagonism of SERINC3 and SERINC5
por: Jin, Steven W., et al.
Publicado: (2020)

Nef Obtained from Individuals with HIV-1 Vary in Their Ability to Antagonize SERINC3- and SERINC5-Mediated HIV-1 Restriction
por: Kruize, Zita, et al.
Publicado: (2021)

In vitro antiproliferative activity of partially purified Trigona laeviceps propolis from Thailand on human cancer cell lines
por: Umthong, Supawadee, et al.
Publicado: (2011)

Depletion of CD8αβ(+) T Cells in Chickens Demonstrates Their Involvement in Protective Immunity towards Marek’s Disease with Respect to Tumor Incidence and Vaccinal Protection
por: Umthong, Supawadee, et al.
Publicado: (2020)

Mitochondrial C11orf83 is a potent Antiviral Protein Independent of interferon production
por: Yang, Yun, et al.
Publicado: (2017)

Rare mutations in the accessory proteins ORF6, ORF7b, and ORF10 of the SARS-CoV-2 genomes
por: Hassan, Sk. Sarif, et al.
Publicado: (2021)

Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection
por: Mantlo, Emily, et al.
Publicado: (2020)

SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV
por: Gonzalez-Enriquez, Gracia Viviana, et al.
Publicado: (2017)

SERINC2-knockdown inhibits proliferation, migration and invasion in lung adenocarcinoma
por: Zeng, Yuan, et al.
Publicado: (2018)

Characterization of Endogenous SERINC5 Protein as Anti-HIV-1 Factor
por: Passos, Vânia, et al.
Publicado: (2019)

HIV envelope tail truncation confers resistance to SERINC5 restriction
por: Haider, Tafhima, et al.
Publicado: (2021)

Potent antiviral effect of silver nanoparticles on SARS-CoV-2
por: Jeremiah, Sundararaj S., et al.
Publicado: (2020)

Natural HIV-1 Nef Polymorphisms Impair SERINC5 Downregulation Activity
por: Jin, Steven W., et al.
Publicado: (2019)

From Beginning to End: Expanding the SERINC3 Interactome Through an in silico Analysis
por: Tu, Mckenzie, et al.
Publicado: (2022)

Serinc2 deficiency causes susceptibility to sepsis-associated acute lung injury
por: Mao, Shuai, et al.
Publicado: (2022)

Antagonism of Host Antiviral Responses by Kaposi's Sarcoma-Associated Herpesvirus Tegument Protein ORF45
por: Zhu, Fan Xiu, et al.
Publicado: (2010)

UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b
por: Zhou, Yuzheng, et al.
Publicado: (2022)

Mannose-Binding Lectins as Potent Antivirals against SARS-CoV-2
por: Grosche, Victória Riquena, et al.
Publicado: (2023)

Expansion of a SARS-CoV-2 Delta variant with an 872 nt deletion encompassing ORF7a, ORF7b and ORF8, Poland, July to August 2021
por: Mazur-Panasiuk, Natalia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_14erjticnc52u28bnti0ff07nb